Beijing SL Pharmaceutical Co., Ltd. (002038.SZ)
CNY 6.29
(1.78%)
CNY 6.29
(1.78%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.01 Billion CNY | -3.99% |
| 2022 | 1.05 Billion CNY | -13.55% |
| 2021 | 1.21 Billion CNY | 9.17% |
| 2020 | 1.11 Billion CNY | -45.18% |
| 2019 | 2.02 Billion CNY | -6.36% |
| 2018 | 2.16 Billion CNY | 74.5% |
| 2017 | 1.24 Billion CNY | 23.0% |
| 2016 | 1 Billion CNY | -12.68% |
| 2015 | 1.15 Billion CNY | -6.95% |
| 2014 | 1.24 Billion CNY | 6.99% |
| 2013 | 1.16 Billion CNY | 15.37% |
| 2012 | 1 Billion CNY | 61.7% |
| 2011 | 622.77 Million CNY | 36.02% |
| 2010 | 457.84 Million CNY | 17.39% |
| 2009 | 390.02 Million CNY | 8.94% |
| 2008 | 358 Million CNY | 50.72% |
| 2007 | 237.53 Million CNY | 65.02% |
| 2006 | 143.93 Million CNY | 21.41% |
| 2005 | 118.55 Million CNY | 27.41% |
| 2004 | 93.05 Million CNY | 30.96% |
| 2003 | 71.05 Million CNY | 42.37% |
| 2002 | 49.9 Million CNY | 55.07% |
| 2001 | 32.18 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 243.51 Million CNY | 2.05% |
| 2024 Q3 | 148.49 Million CNY | 2.83% |
| 2024 Q2 | 144.41 Million CNY | -40.69% |
| 2023 Q1 | 296.57 Million CNY | 32.88% |
| 2023 Q2 | 286.92 Million CNY | -3.25% |
| 2023 Q3 | 193.12 Million CNY | -32.69% |
| 2023 Q4 | 238.63 Million CNY | 23.57% |
| 2023 FY | 1 Billion CNY | -3.99% |
| 2022 Q2 | 279.66 Million CNY | 1.86% |
| 2022 Q3 | 272.75 Million CNY | -2.47% |
| 2022 Q4 | 223.19 Million CNY | -18.17% |
| 2022 FY | 1.05 Billion CNY | -13.55% |
| 2022 Q1 | 274.55 Million CNY | -8.92% |
| 2021 Q3 | 288.85 Million CNY | -22.29% |
| 2021 Q4 | 301.43 Million CNY | 4.35% |
| 2021 FY | 1.21 Billion CNY | 9.17% |
| 2021 Q2 | 371.69 Million CNY | 47.01% |
| 2021 Q1 | 252.83 Million CNY | -6.46% |
| 2020 Q3 | 305.27 Million CNY | -10.87% |
| 2020 Q1 | 194.66 Million CNY | -57.11% |
| 2020 Q2 | 342.5 Million CNY | 75.95% |
| 2020 Q4 | 270.29 Million CNY | -11.46% |
| 2020 FY | 1.11 Billion CNY | -45.18% |
| 2019 FY | 2.02 Billion CNY | -6.36% |
| 2019 Q2 | 584.66 Million CNY | 25.57% |
| 2019 Q1 | 465.62 Million CNY | -24.47% |
| 2019 Q3 | 525.54 Million CNY | -10.11% |
| 2019 Q4 | 453.87 Million CNY | -13.64% |
| 2018 Q2 | 540.6 Million CNY | 22.83% |
| 2018 Q4 | 616.44 Million CNY | 8.09% |
| 2018 FY | 2.16 Billion CNY | 74.5% |
| 2018 Q1 | 440.12 Million CNY | -6.04% |
| 2018 Q3 | 570.29 Million CNY | 5.49% |
| 2017 Q3 | 307.56 Million CNY | 28.37% |
| 2017 Q2 | 239.59 Million CNY | 5.78% |
| 2017 Q1 | 226.51 Million CNY | -27.22% |
| 2017 FY | 1.24 Billion CNY | 23.0% |
| 2017 Q4 | 468.39 Million CNY | 52.29% |
| 2016 Q1 | 258.84 Million CNY | -22.33% |
| 2016 FY | 1 Billion CNY | -12.68% |
| 2016 Q4 | 311.24 Million CNY | 37.57% |
| 2016 Q3 | 226.24 Million CNY | 5.96% |
| 2016 Q2 | 213.51 Million CNY | -17.51% |
| 2015 Q4 | 333.27 Million CNY | 17.13% |
| 2015 Q2 | 261.44 Million CNY | -5.72% |
| 2015 FY | 1.15 Billion CNY | -6.95% |
| 2015 Q1 | 277.3 Million CNY | -19.79% |
| 2015 Q3 | 284.52 Million CNY | 8.83% |
| 2014 Q3 | 310.33 Million CNY | 3.97% |
| 2014 Q4 | 345.73 Million CNY | 11.41% |
| 2014 FY | 1.24 Billion CNY | 6.99% |
| 2014 Q1 | 288.38 Million CNY | -13.18% |
| 2014 Q2 | 298.49 Million CNY | 3.51% |
| 2013 Q1 | 231.01 Million CNY | -37.77% |
| 2013 Q3 | 285.26 Million CNY | -8.96% |
| 2013 Q4 | 332.15 Million CNY | 16.44% |
| 2013 FY | 1.16 Billion CNY | 15.37% |
| 2013 Q2 | 313.34 Million CNY | 35.64% |
| 2012 Q2 | 234.9 Million CNY | 41.54% |
| 2012 Q1 | 165.96 Million CNY | -11.06% |
| 2012 Q4 | 371.23 Million CNY | 58.03% |
| 2012 FY | 1 Billion CNY | 61.7% |
| 2012 Q3 | 234.91 Million CNY | 0.0% |
| 2011 FY | 622.77 Million CNY | 36.02% |
| 2011 Q4 | 186.6 Million CNY | 19.14% |
| 2011 Q3 | 156.62 Million CNY | 2.7% |
| 2011 Q1 | 127.03 Million CNY | -10.01% |
| 2011 Q2 | 152.51 Million CNY | 20.06% |
| 2010 Q1 | 89.7 Million CNY | -16.05% |
| 2010 FY | 457.84 Million CNY | 17.39% |
| 2010 Q2 | 126.67 Million CNY | 41.22% |
| 2010 Q3 | 100.3 Million CNY | -20.82% |
| 2010 Q4 | 141.15 Million CNY | 40.73% |
| 2009 FY | 390.02 Million CNY | 8.94% |
| 2009 Q4 | 106.85 Million CNY | -5.76% |
| 2009 Q3 | 113.37 Million CNY | 20.47% |
| 2009 Q2 | 94.11 Million CNY | 24.36% |
| 2009 Q1 | 75.67 Million CNY | -14.68% |
| 2008 Q4 | 88.7 Million CNY | -19.59% |
| 2008 Q3 | 110.3 Million CNY | 14.88% |
| 2008 Q2 | 96.01 Million CNY | 52.46% |
| 2008 Q1 | 62.97 Million CNY | -13.4% |
| 2008 FY | 358 Million CNY | 50.72% |
| 2007 Q1 | 32.72 Million CNY | -23.19% |
| 2007 FY | 237.53 Million CNY | 65.02% |
| 2007 Q4 | 72.72 Million CNY | 6.2% |
| 2007 Q3 | 68.48 Million CNY | 7.68% |
| 2007 Q2 | 63.59 Million CNY | 94.33% |
| 2006 Q1 | 28.44 Million CNY | -18.91% |
| 2006 Q2 | 40.27 Million CNY | 41.57% |
| 2006 FY | 143.93 Million CNY | 21.41% |
| 2006 Q3 | 33.39 Million CNY | -17.07% |
| 2006 Q4 | 42.61 Million CNY | 27.58% |
| 2005 Q1 | 19.25 Million CNY | -28.06% |
| 2005 Q2 | 33.68 Million CNY | 74.9% |
| 2005 FY | 118.55 Million CNY | 27.41% |
| 2005 Q3 | 31.49 Million CNY | -6.51% |
| 2005 Q4 | 35.08 Million CNY | 11.4% |
| 2004 Q3 | 22.5 Million CNY | -3.92% |
| 2004 Q2 | 23.42 Million CNY | 11.96% |
| 2004 Q4 | 26.77 Million CNY | 18.94% |
| 2004 FY | 93.05 Million CNY | 30.96% |
| 2004 Q1 | 20.92 Million CNY | -0.23% |
| 2003 Q4 | 20.97 Million CNY | 8.81% |
| 2003 FY | 71.05 Million CNY | 42.37% |
| 2003 Q3 | 19.27 Million CNY | 0.0% |
| 2002 FY | 49.9 Million CNY | 55.07% |
| 2001 FY | 32.18 Million CNY | 0.0% |